Literature DB >> 15106721

Immunogenicity and safety of 10 mg and 20 mg doses of Genevac-B, a recombinant hepatitis B vaccine, in healthy adolescents.

V Vijayakumar, M Shraddha, N Subhadra, S Saravanan, T Sundararajan, S P Thyagarajan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15106721

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN： 0254-8860


× No keyword cloud information.
  2 in total

1.  Comparison of two hepatitis B vaccines (GeneVac-B and Engerix-B) in healthy infants in India.

Authors:  Virbhadra Somani; B S Srikanth; M Mohan; P S Kulkarni
Journal:  Clin Vaccine Immunol       Date:  2006-06

2.  Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India.

Authors:  Vijayakumar Velu; Subhadra Nandakumar; Saravanan Shanmugam; Suresh-Sakharam Jadhav; Prasad-Suryakant Kulkarni; Sadras-Panchatcharam Thyagarajan
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.